newsfilter
← Latest News
PR Newswire·

Rigel to Present at the Jefferies Global Healthcare Conference in London

  • Rigel Pharmaceuticals (Nasdaq: RIGL) announced President & CEO Raul Rodriguez will present a company overview at the Jefferies Global Healthcare Conference.
  • The presentation is scheduled for Tuesday, November 17, 2026, at 12:00 p.m. GMT (7:00 a.m. ET) in London.
  • Live webcasts & archived recordings are accessible via the Investor Relations section of www.rigel.com.
  • Rigel is a commercial-stage biotechnology firm founded in 1996, based in South San Francisco, California.
  • The company focuses on discovering & developing novel therapies for hematologic disorders & cancer.
  • Investor inquiries should contact Rigel Pharmaceuticals at 650.624.1232.
  • Media inquiries should contact David Rosen at Argot Partners at 646.461.6387.
Company
Rigel Pharmaceuticals, Inc.
Keywords
Rigel Pharmaceuticals, Inc.